News – Page 744 – Endpoints News

The packed PD-(L)1 game just got another player — a low-profile biosimilars company looking to branch out with a ...

5 years ago

Exclusive: Johns Hopkins professor and biotech colleagues tout new tech to test Covid-19 vaccine response

5 years ago

Khosla Ventures helps seed a next-gen regenerative medicines startup boasting AI-based stem cell culturing technology

5 years ago

Exclusive: Third Rock's stealthy MOMA Therapeutics taps a longtime Millennium, Takeda vet as CEO

5 years ago

Horizon nabs another rare disease pipeline for the portfolio in $3B buyout. And AstraZeneca — a future rival — is ...

5 years ago

Biotech partner drops GlaxoSmithKline’s adjuvant as it moves Covid-19 vaccine into PhII/III, citing ...

5 years ago

Covid-19 roundup: Bayer expands deal with CureVac to produce shots; UK orders more Valneva vaccines

5 years ago

In pursuit of an HIV cure, Gilead jumps into a T cell-driving vaccine program with a $785M deal that triggers PhI

5 years ago

#WCLC21: Merck pokes Bristol Myers in the eye with Keytruda data showing safety red flags in Yervoy combo trial

5 years ago

#WCLC21: AstraZeneca's EGFR inhibitor Tagrisso cuts relapse, death risks in patients with and without prior ...

5 years ago

Josh Bilenker ends his brief role in an unusual experiment at Eli Lilly, bowing out as head of their Loxo cancer R&D ...

5 years ago

Catabasis Pharmaceuticals snaps up HAE antibody in buyout; Gladstone, UCSF scientist spearhead launch of neuro ...

5 years ago

Though still struggling, Bellicum can resume trial on CAR-T hopeful after FDA lifts clinical hold

5 years ago

WCLC: AstraZeneca builds case for growing ADC pipeline with double wins in advanced lung cancer

5 years ago

Gates Foundation backs gene therapy pioneers' second-gen Covid-19 vaccine

5 years ago

Michael Yang leads list of moves at ViaCyte, succeeding Paul Laikind as CEO; Qasim Rizvi named CEO of Takeda partner ...

5 years ago

Is it time to stock up on wine? This pandemic could stretch out — and that has some major market implications

5 years ago

Illumina co-founder Mark Chee moves from the genome to the proteome with upstart Encodia

5 years ago

J&J heralds 66% efficacy for single-dose shot, but falls short of mRNA rivals

5 years ago

The FDA delays its decision on Biogen's controversial pitch on its Alzheimer's drug — and the biotech's shares soar

5 years ago

Covid-19 roundup: AstraZeneca gets EMA thumbs up for vaccine amid bitter feud with EU; Novartis jumps in to ...

5 years ago

The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic

5 years ago

J&J pushes new amivantamab data for NSCLC subset, trying to bolster case for quick FDA approval

5 years ago

Novavax says its Covid-19 vaccine proved 89.3% effective in UK trial including variant — while South African ...

5 years ago

First page Previous page 741 742 743744745 746 747 Next page Last page